Yale Spinout Cloverleaf Bio Raises $33M Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator